Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Martin Samuel Bates | SVP AND CFO | Jun 14 '24 | Option Exercise | 10.16 | 20,169 | 204,990 | 45,297 | Jun 18 04:05 PM | Martin Samuel Bates | SVP AND CFO | Jun 14 '24 | Sale | 35.42 | 17,172 | 608,315 | 28,125 | Jun 18 04:05 PM | Crowley Elizabeth | SR. VP & CPDO | Jun 14 '24 | Option Exercise | 10.38 | 30,000 | 311,400 | 39,074 | Jun 18 04:04 PM | Crowley Elizabeth | SR. VP & CPDO | Jun 14 '24 | Sale | 34.87 | 30,000 | 1,045,962 | 9,074 | Jun 18 04:04 PM | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Jun 11 '24 | Option Exercise | 2.71 | 15,000 | 40,650 | 17,115 | Jun 13 04:05 PM | Crowley Elizabeth | SR. VP & CPDO | Jun 07 '24 | Option Exercise | 9.70 | 15,000 | 145,474 | 24,074 | Jun 11 04:02 PM | Crowley Elizabeth | SR. VP & CPDO | Jun 07 '24 | Sale | 35.06 | 15,000 | 525,873 | 9,074 | Jun 11 04:02 PM | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Jun 07 '24 | Sale | 35.26 | 45,000 | 1,586,844 | 2,115 | Jun 11 04:01 PM | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Jun 05 '24 | Option Exercise | 10.38 | 9,540 | 99,025 | 35,464 | Jun 07 04:05 PM | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | Jun 03 '24 | Option Exercise | 10.25 | 64,658 | 662,575 | 71,752 | Jun 05 04:06 PM | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | Jun 03 '24 | Sale | 33.65 | 58,369 | 1,964,088 | 13,383 | Jun 05 04:06 PM | Wright Richard M. | SR. VP & CCO | Jun 03 '24 | Option Exercise | 18.79 | 67,469 | 1,267,540 | 67,677 | Jun 05 04:05 PM | Wright Richard M. | SR. VP & CCO | Jun 03 '24 | Sale | 33.72 | 46,844 | 1,579,353 | 20,833 | Jun 05 04:05 PM | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Jun 03 '24 | Option Exercise | 10.38 | 8,006 | 83,102 | 33,930 | Jun 05 04:04 PM | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Jun 03 '24 | Sale | 33.60 | 8,006 | 269,002 | 25,924 | Jun 05 04:04 PM | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | May 30 '24 | Option Exercise | 3.75 | 33,719 | 126,301 | 45,813 | Jun 03 04:06 PM | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | May 30 '24 | Sale | 34.07 | 38,719 | 1,319,156 | 7,094 | Jun 03 04:06 PM | Martin Samuel Bates | SVP AND CFO | May 30 '24 | Option Exercise | 10.38 | 25,000 | 259,500 | 60,128 | Jun 03 04:05 PM | Martin Samuel Bates | SVP AND CFO | May 30 '24 | Sale | 34.05 | 35,000 | 1,191,774 | 25,128 | Jun 03 04:05 PM | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | May 30 '24 | Option Exercise | 5.80 | 20,853 | 120,979 | 22,713 | Jun 03 04:04 PM | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | May 30 '24 | Sale | 33.73 | 20,853 | 703,334 | 1,860 | Jun 03 04:04 PM | Crowley Elizabeth | SR. VP & CPDO | May 30 '24 | Option Exercise | 4.01 | 42,945 | 172,397 | 47,671 | Jun 03 04:04 PM | Crowley Elizabeth | SR. VP & CPDO | May 30 '24 | Sale | 33.64 | 38,597 | 1,298,384 | 9,074 | Jun 03 04:04 PM | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Feb 13 '24 | Option Exercise | 3.86 | 24,166 | 93,163 | 25,924 | Feb 15 04:05 PM | Martin Samuel Bates | SVP AND CFO | Jan 02 '24 | Option Exercise | 2.78 | 10,750 | 29,885 | 35,128 | Jan 04 04:05 PM |
|